[96a5a0]: / output / chiaCancer / identified / NCT03333655_identified.json

Download this file

181 lines (181 with data), 7.3 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
{
"info": {
"nct_id": "NCT03333655",
"official_title": "A Multicenter Study to Explore the Mechanism of Acquired Immune Escape In Patients With Metastatic Cancer Progressing on Checkpoint Inhibitor Therapy",
"inclusion_criteria": "* Response assessment of complete response (CR), partial response (PR), or long-term stable disease (SD) for >6 months with a cancer immunotherapy treatment for metastatic cancer or hematologic malignancies either through a marketed CPI or through participation in a Roche/Genentech CPI clinical trial.\n* Availability of tissue sample.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Pregnant, lactating, or intending to become pregnant during the study.\n* Participants receiving CPI treatment as part of a non-Roche/Genentech clinical trial.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Response assessment of complete response (CR), partial response (PR), or long-term stable disease (SD) for >6 months with a cancer immunotherapy treatment for metastatic cancer or hematologic malignancies either through a marketed CPI or through participation in a Roche/Genentech CPI clinical trial.",
"criterions": [
{
"exact_snippets": [
"complete response (CR)"
],
"criterion": "response assessment",
"requirement_type": "type",
"expected_value": "complete response"
},
{
"exact_snippets": [
"partial response (PR)"
],
"criterion": "response assessment",
"requirement_type": "type",
"expected_value": "partial response"
},
{
"exact_snippets": [
"long-term stable disease (SD) for >6 months"
],
"criterion": "response assessment",
"requirement_type": "type",
"expected_value": "long-term stable disease"
},
{
"exact_snippets": [
"cancer immunotherapy treatment"
],
"criterion": "treatment type",
"requirement_type": "type",
"expected_value": "cancer immunotherapy"
},
{
"exact_snippets": [
"metastatic cancer"
],
"criterion": "cancer type",
"requirement_type": "type",
"expected_value": "metastatic cancer"
},
{
"exact_snippets": [
"hematologic malignancies"
],
"criterion": "cancer type",
"requirement_type": "type",
"expected_value": "hematologic malignancies"
},
{
"exact_snippets": [
"marketed CPI"
],
"criterion": "treatment source",
"requirement_type": "source",
"expected_value": "marketed CPI"
},
{
"exact_snippets": [
"participation in a Roche/Genentech CPI clinical trial"
],
"criterion": "treatment source",
"requirement_type": "source",
"expected_value": "Roche/Genentech CPI clinical trial"
}
]
},
{
"line": "* Availability of tissue sample.",
"criterions": [
{
"exact_snippets": [
"Availability of tissue sample"
],
"criterion": "tissue sample",
"requirement_type": "availability",
"expected_value": true
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
}
],
"exclusion_lines": [
{
"line": "* Pregnant, lactating, or intending to become pregnant during the study.",
"criterions": [
{
"exact_snippets": [
"Pregnant"
],
"criterion": "pregnancy",
"requirement_type": "status",
"expected_value": true
},
{
"exact_snippets": [
"lactating"
],
"criterion": "lactation",
"requirement_type": "status",
"expected_value": true
},
{
"exact_snippets": [
"intending to become pregnant during the study"
],
"criterion": "intention to become pregnant",
"requirement_type": "status",
"expected_value": true
}
]
},
{
"line": "* Participants receiving CPI treatment as part of a non-Roche/Genentech clinical trial.",
"criterions": [
{
"exact_snippets": [
"Participants receiving CPI treatment"
],
"criterion": "CPI treatment",
"requirement_type": "receipt",
"expected_value": true
},
{
"exact_snippets": [
"non-Roche/Genentech clinical trial"
],
"criterion": "clinical trial sponsor",
"requirement_type": "sponsor",
"expected_value": [
"non-Roche",
"non-Genentech"
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}